Skip to main content
Premium Trial:

Request an Annual Quote

Hyseq, UCSF License Heart Database to Celera Diagnostics

NEW YORK, Sept. 9-Celera Diagnostics has signed an agreement with Hyseq Pharmaceuticals and the University of California at San Francisco for access to a large collection of samples from cardiovascular patients, Hyseq announced today.


The database includes more than 12,000 DNA samples and related clinical information.


Celera will use the collection to study the genetics of cardiovascular disease.


The license is non-exclusive. Financial terms were not disclosed.


For more information, see the press release.


The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.